Additionally, ADU-S100 in combination with PD-1/cyclooxygenase-2 blockade suppresses peritoneal dissemination of colon cancer and elicits durable tumour immunity in colon cancer (Lee et al., 2021). Here, PDCD1 is linked to colonic neoplasm.